IRIS
MORETTA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 70.658
AS - Asia 6.205
NA - Nord America 4.815
Continente sconosciuto - Info sul continente non disponibili 586
SA - Sud America 528
AF - Africa 92
OC - Oceania 3
Totale 82.887
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 69.515
US - Stati Uniti d'America 4.443
SG - Singapore 2.739
CN - Cina 1.558
VN - Vietnam 1.028
FR - Francia 557
BR - Brasile 330
BD - Bangladesh 306
HK - Hong Kong 201
FI - Finlandia 151
CA - Canada 147
DE - Germania 111
JP - Giappone 83
AR - Argentina 78
MX - Messico 76
GB - Regno Unito 71
CH - Svizzera 67
IN - India 42
ID - Indonesia 38
NL - Olanda 33
IQ - Iraq 32
JM - Giamaica 31
EC - Ecuador 29
RU - Federazione Russa 27
CR - Costa Rica 26
PH - Filippine 26
CO - Colombia 25
ZA - Sudafrica 22
HN - Honduras 19
PK - Pakistan 19
ES - Italia 17
GT - Guatemala 16
VE - Venezuela 16
PY - Paraguay 15
TH - Thailandia 15
CL - Cile 14
TW - Taiwan 14
PL - Polonia 13
IE - Irlanda 12
TT - Trinidad e Tobago 12
UA - Ucraina 12
UZ - Uzbekistan 12
MY - Malesia 10
PE - Perù 10
JO - Giordania 9
KE - Kenya 9
MA - Marocco 9
PR - Porto Rico 9
SE - Svezia 9
NI - Nicaragua 8
SA - Arabia Saudita 8
DZ - Algeria 7
SV - El Salvador 7
EG - Egitto 6
KR - Corea 6
RO - Romania 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BB - Barbados 5
BE - Belgio 5
CZ - Repubblica Ceca 5
GA - Gabon 5
MM - Myanmar 5
NP - Nepal 5
AO - Angola 4
AT - Austria 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
SI - Slovenia 4
TR - Turchia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CG - Congo 3
GE - Georgia 3
GY - Guiana 3
IR - Iran 3
LT - Lituania 3
MD - Moldavia 3
PT - Portogallo 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AG - Antigua e Barbuda 2
ET - Etiopia 2
GF - Guiana Francese 2
GP - Guadalupe 2
HR - Croazia 2
ML - Mali 2
NG - Nigeria 2
PA - Panama 2
SC - Seychelles 2
Totale 82.267
Salva come PNG Salva come JPEG
Città #
Genova 46.502
Genoa 13.060
Rapallo 5.525
Vado Ligure 3.870
San Jose 1.296
Singapore 1.237
Lauterbourg 524
Ashburn 387
Ho Chi Minh City 306
New York 252
Hanoi 236
Beijing 211
Hong Kong 186
Helsinki 151
Santa Clara 133
Bordighera 120
Frankfurt am Main 95
Council Bluffs 85
Tokyo 79
Los Angeles 74
Milan 72
Zurich 67
Haiphong 50
Chicago 48
Dallas 47
Mexico City 44
Tianjin 44
Buffalo 43
Phoenix 38
Atlanta 37
Da Nang 34
Rome 32
Houston 31
Montreal 30
Shanghai 28
São Paulo 28
San Francisco 23
Orem 22
Queens 21
Biên Hòa 20
Des Moines 20
Philadelphia 20
San José 20
Toronto 20
Columbus 19
Kingston 19
Amsterdam 18
Brooklyn 18
Naples 18
Washington 18
City of London 17
Las Vegas 16
Princeton 16
Baghdad 15
Denver 15
Duarte 15
Florence 15
Hải Dương 15
Turin 14
Valenza 14
London 13
Miami 13
Ninh Bình 13
The Bronx 12
Bangkok 11
Boardman 11
Dublin 11
Tashkent 11
Baltimore 10
Cardiff 10
Jakarta 10
Omaha 10
Amman 9
Boston 9
Can Tho 9
Charlotte 9
Guatemala City 9
Ha Long 9
Hamilton 9
Lima 9
Mumbai 9
Palermo 9
Paris 9
Pittsburgh 9
Thái Nguyên 9
Alexandria 8
Bologna 8
Catania 8
Chennai 8
Fayetteville 8
Fortaleza 8
Guangzhou 8
Guayaquil 8
Jacksonville 8
Johannesburg 8
Nairobi 8
Poplar 8
Santiago 8
Buenos Aires 7
Cape Town 7
Totale 75.800
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 476
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 264
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 260
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 249
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 243
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 240
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 236
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 230
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 228
Dendritic cell editing by natural killer cells. 227
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 222
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 221
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 220
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 217
2B4 functions as a co-receptor in human NK cell activation 216
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 216
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 213
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 212
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 208
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 207
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 206
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 205
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 204
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 203
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. 203
Interactions Between Mesenchymal Stem Cells and Dendritic Cells. 201
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 199
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 198
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 196
Role of Nrf2, HO-1 and GSH in neuroblastoma cell resistance to bortezomib 196
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 196
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 195
Effect of tumor cells and tumor microenvironment on NK-cell function. 193
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 192
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 192
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 192
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 191
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 191
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2 191
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 191
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 191
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 191
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 191
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. 191
T gamma delta cells and their subsets in blood and synovial tissue from rheumatoid arthritis patients. 190
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 190
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 190
HO-1 up-regulation: A key point in high-risk neuroblastoma resistance to bortezomib. 189
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 187
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 187
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 187
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 185
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance 185
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 184
Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. 184
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 184
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 184
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 184
Human innate lymphoid cells 184
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 184
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 183
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 183
Human NK receptors: from the molecules to the therapy of high risk leukemias. 183
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 183
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 182
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 182
HO-1 induction in cancer progression: A matter of cell adaptation 182
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 181
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 181
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 181
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 181
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 180
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 178
Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. 178
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 177
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 177
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 177
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 176
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 176
Surface antigens specifically expressed by activated T cells in humans. 175
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 175
Characterization of human afferent lymph dendritic cells from seroma fluids. 175
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 174
Alloreactive natural killer cells in targeting high-risk leukaemias. 174
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 174
MSC and innate immune cell interactions: A lesson from human decidua 174
Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity. 174
KIR and KIR ligand polymorphism: a new area for clinical applications? 174
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 174
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 173
A novel pathway of human B cell activation initiated by CK226 surface antigen. 173
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 173
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 173
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 172
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. 172
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 171
Stimulatory receptors in NK and T cells. 171
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 171
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 171
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 171
Totale 19.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.277
article - articoli 232.794
book - libri 348
conference - conferenze 8.618
curatela - curatele 0
other - altro 0
patent - brevetti 1.549
selected - selezionate 0
volume - volumi 2.968
Totale 492.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.215 208 533 780 816 378 316 413 1.714 240 661 278 878
2022/20236.609 703 374 94 656 1.098 1.296 6 538 1.187 45 533 79
2023/20243.025 148 457 88 402 296 514 130 172 217 68 172 361
2024/20258.945 146 757 367 557 1.455 817 855 1.294 369 434 783 1.111
2025/202615.465 1.711 401 882 1.377 1.989 1.775 2.721 704 941 1.482 632 850
2026/20271.776 1.776 0 0 0 0 0 0 0 0 0 0 0
Totale 82.887